Harvey Robert Klingensmith - 01 Apr 2023 Form 4 Insider Report for CORE LABORATORIES N V

Role
Director
Signature
/s/ Mark Tattoli, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
01 Apr 2023
Net transactions value
$0
Form type
4
Filing time
03 Apr 2023, 13:36:21 UTC
Previous filing
04 Apr 2022
Next filing
02 Apr 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CLB Common Shares Options Exercise $0 +5,485 +26% $0.000000 26,226 01 Apr 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLB Restricted Shares Award $0 +6,419 $0.000000 6,419 01 Apr 2023 Common Shares 6,419 $0.000000 Direct F1
transaction CLB Restricted Shares Options Exercise $0 -5,485 -100% $0.000000* 0 01 Apr 2023 Common Shares 5,485 $0.000000 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Restricted Shares will vest, without performance criteria, at the end of a one-year vesting period on April 1, 2024, subject to the terms of issuance.
F2 The Restricted Shares vested at the end of a one-year vesting period ending April 1, 2023.